Skip to content

PECS and Parasternal Block for Breast Surgery

Observational Study to Evaluated Efficacy of Parasternal and PECS Blocks Association in Breast Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03043755
Acronym
PARAST
Enrollment
32
Registered
2017-02-06
Start date
2016-07-31
Completion date
2017-02-28
Last updated
2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastectomy, Quadrantectomy

Brief summary

Propose to evaluate efficacy of association between US guide parasternal block and pectorals nerves block (PECS) as anesthetic option for breast surgery (medial quadrantectomy and simple mastectomy). All patients undergoing medial quadrantectomy and simple mastectomy in 6 months period will be observed. All patients receive: US guide parasternal block at T4 and T6 space with 6ml of ropivacaine 0,75% and PECS type 2 block performed with 24ml of ropivacaine 0,75%. During surgery patients receive light sedation with continuous infusion of propofol Will be observed: Additional local anesthetic infiltration from surgeon. Pain at rest and during movement quantified as Numerical Rating Scores (0-10) during the first 12 hours postoperatively. Eventual side effects such as nausea/vomiting.

Interventions

None listed

Sponsors

Istituti Ospitalieri di Cremona
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age\> 18 years; * ASA score I - II - III; * undergoing elective medial quadrantectomy breast surgery; * undergoing elective mastectomy not reconstruction breast surgery; * signed informed consent;

Exclusion criteria

* chronic therapy with opioids/ antidepressants; * urgent/emergent surgery; * postoperative transfer to the intensive care unit; * known allergy to any drug medication; * local skin infection; * epilepsy; * alcohol or drug abuse;

Design outcomes

Primary

MeasureTime frameDescription
Local Anesthetic infiltrationintraoperatory periodQuantify amount of local anesthetic infiltration from surgeon to get perfect anesthesia
Convention in general anesthesiapreoperative periodNumber of patients require general anestesia to proceed to surgery

Secondary

MeasureTime frameDescription
Pain12 hours postoperativelyRest and in mouvement pain as NRS scale
PONV12 hours postoperativelyPostoperative nausea/vomiting incidence

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026